BAHR has advised Solvay on the conclusion of a joint venture with Aquatiq
BAHR has advised Solvay, an advanced materials and specialty chemicals company and a leader in hydrogen peroxide, on the conclusion of a joint venture agreement with Aquatiq regarding the company Aqua Pharma. The joint venture reinforces the parties long-term collaboration to serve aquaculture customers. The joint venture aims to become a key aquaculture player by offering a wide range of sustainable and efficient solutions for sea lice control and amoebic gill disease to the salmon industry.
The team has i.a. consisted of Lisa Marie Opdahl, Senad Saric and Erik Tørrissen from our Fisheries and Aquaculture team and Anne Dahl Frisak from Corporate M&A.